Skip to main content
Log in

Steroidtherapie und Kawasaki-Syndrom

Aussagekraft vorliegender Studien

Steroid therapy and Kawasaki syndrome

Significance of available studies

  • Leserforum
  • Published:
Monatsschrift Kinderheilkunde Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Literatur

  1. Kobayashi T et al (2012) Efficacy of immunoglobulin plus prednisolone for prevention of coronary artery abnormalities in severe Kawasaki disease (RAISE study): a randomised, open-label, blinded-endpoints trial. Lancet 379(9826):1613–1620

    Article  CAS  PubMed  Google Scholar 

  2. Kim BY et al (2016) Non-responders to intravenous immunoglobulin and coronary artery dilatation in Kawasaki disease: predictive parameters in korean children. Korean Circ J 46(4):542–549

    Article  PubMed  PubMed Central  Google Scholar 

  3. Tang Y et al (2016) Prediction of intravenous immunoglobulin resistance in Kawasaki disease in an East China population. Clin Rheumatol 35(11):2771–2776

    Article  PubMed  Google Scholar 

  4. Davies S et al (2015) Predicting IVIG resistance in UK Kawasaki disease. Arch Dis Child 100(4):366–368

    Article  PubMed  Google Scholar 

  5. Sleeper LA et al (2011) Evaluation of Kawasaki disease risk-scoring systems for intravenous immunoglobulin resistance. J Pediatr 158(5):831–835.e3

    Article  PubMed  Google Scholar 

  6. Kobayashi T et al (2006) Prediction of intravenous immunoglobulin unresponsiveness in patients with Kawasaki disease. Circulation 113(22):2606–2612

    Article  PubMed  Google Scholar 

  7. Chen S et al (2013) Intravenous immunoglobulin plus corticosteroid to prevent coronary artery abnormalities in Kawasaki disease: a meta-analysis. Heart 99(2):76–82

    Article  CAS  PubMed  Google Scholar 

  8. Chen S et al (2016) Coronary artery complication in Kawasaki disease and the importance of early intervention : A systematic review and meta-analysis. JAMA Pediatr. doi:10.1001/jamapediatrics.2016.2055

    Google Scholar 

  9. Newburger JW et al (2007) Randomized trial of pulsed corticosteroid therapy for primary treatment of Kawasaki disease. N Engl J Med 356(7):663–675

    Article  CAS  PubMed  Google Scholar 

  10. Okada Y et al (2003) Effect of corticosteroids in addition to intravenous gamma globulin therapy on serum cytokine levels in the acute phase of Kawasaki disease in children. J Pediatr 143(3):363–367

    Article  CAS  PubMed  Google Scholar 

  11. Sundel RP et al (2003) Corticosteroids in the initial treatment of Kawasaki disease: report of a randomized trial. J Pediatr 142(6):611–616

    Article  CAS  PubMed  Google Scholar 

  12. Ogata S et al (2012) Corticosteroid pulse combination therapy for refractory Kawasaki disease: a randomized trial. Pediatrics 129(1): p:e17–23

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to A. Jakob.

Ethics declarations

Interessenkonflikt

A. Jakob und M. Hufnagel geben an, dass kein Interessenkonflikt besteht.

Additional information

Redaktion

R. Berner, Dresden

B. Koletzko, München

W. Sperl, Salzburg

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Jakob, A., Hufnagel, M. Steroidtherapie und Kawasaki-Syndrom. Monatsschr Kinderheilkd 165, 184–185 (2017). https://doi.org/10.1007/s00112-016-0218-4

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00112-016-0218-4

Navigation